Department Nutrition, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.
Cardiovasc Drugs Ther. 2009 Dec;23(6):459-69. doi: 10.1007/s10557-009-6208-1.
During reperfusion, following myocardial ischemia, uncompensated loss of citric acid cycle (CAC) intermediates may impair CAC flux and energy transduction. Propionate has an anaplerotic effect when converted to the CAC intermediate succinyl-CoA, and may improve contractile recovery during reperfusion. Antioxidant therapy with N-acetylcysteine decreases reperfusion injury. To synergize the antioxidant effects of cysteine with the anaplerotic effects of propionate, we synthesized a novel bi-functional compound, N,S-dipropionyl cysteine ethyl ester (DPNCE) and tested its anaplerotic and anti-oxidative capacity in anesthetized pigs.
Ischemia was induced by a 70% reduction in left anterior descending coronary artery flow for one hour, followed by 1 h of reperfusion. After 30 min of ischemia and throughout reperfusion animals were treated with saline or intravenous DPNCE (1.5 mg x kg(-1) x min(-1), n = 8/group). Arterial concentrations and myocardial propionate, cysteine, free fatty acids, glucose and lactate uptakes, cardiac mechanical functions, myocardial content of CAC intermediates and oxidative stress were assessed.
Ischemia resulted in reduction in myocardial tissue concentration of CAC intermediates. DPNCE treatment elevated arterial propionate and cysteine concentrations and myocardial propionate uptake, and increased myocardial concentrations of citrate, succinate, fumarate, and malate compared to saline treated animals. DPNCE treatment did not affect blood pressure or myocardial contractile function, but increased arterial free fatty acid concentration and myocardial fatty acid uptake. Arterial cysteine concentration was elevated by DPNCE, but there was negligible myocardial cysteine uptake, and no change in markers of oxidative stress.
DPNCE elevated arterial cysteine and propionate, and increased myocardial concentration of CAC intermediates, but did not affect mechanical function or oxidative stress.
在心肌缺血再灌注期间,柠檬酸循环(CAC)中间产物的代偿性丧失可能会损害 CAC 流量和能量转导。丙酸盐在转化为 CAC 中间产物琥珀酰辅酶 A 时具有补充作用,并且可能改善再灌注期间的收缩恢复。用 N-乙酰半胱氨酸进行抗氧化治疗可减少再灌注损伤。为了使半胱氨酸的抗氧化作用与丙酸盐的补充作用协同作用,我们合成了一种新型双功能化合物 N,S-二丙酰半胱氨酸乙酯(DPNCE),并在麻醉猪中测试了其补充作用和抗氧化能力。
通过将左前降支冠状动脉血流减少 70%来诱导缺血 1 小时,然后再进行 1 小时的再灌注。在缺血 30 分钟后并在整个再灌注期间,动物用生理盐水或静脉内 DPNCE(1.5mg x kg(-1)x min(-1),n = 8/组)处理。评估动脉浓度和心肌丙酸盐、半胱氨酸、游离脂肪酸、葡萄糖和乳酸摄取、心脏机械功能、CAC 中间产物的心肌含量和氧化应激。
缺血导致心肌组织中 CAC 中间产物的浓度降低。与生理盐水处理的动物相比,DPNCE 处理可提高动脉丙酸盐和半胱氨酸浓度以及心肌丙酸盐摄取,并增加心肌中柠檬酸、琥珀酸、延胡索酸和苹果酸的浓度。DPNCE 处理不影响血压或心肌收缩功能,但增加了动脉游离脂肪酸浓度和心肌脂肪酸摄取。DPNCE 可提高动脉半胱氨酸浓度,但心肌摄取半胱氨酸的量可忽略不计,且氧化应激标志物无变化。
DPNCE 可提高动脉半胱氨酸和丙酸盐的浓度,并增加 CAC 中间产物在心肌中的浓度,但不影响机械功能或氧化应激。